Sandy K Yip, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 2821 W Horizon Ridge Pkwy Ste 100, Henderson, NV 89052 Phone: 702-732-2774 Fax: 702-737-7495 |
Dr. Jayaprakash Narayan Yalamanchili, MD Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 870 Seven Hills Dr Ste 102, Henderson, NV 89052 Phone: 702-384-5101 Fax: 702-436-7266 |
Andrew Sean Mcknight, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 2485 W Horizon Ridge Pkwy Ste 100, Henderson, NV 89052 Phone: 702-212-5889 Fax: 702-212-5890 |
Bob Kyo Miyake, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 2485 W Horizon Ridge Pkwy, Suite 100, Henderson, NV 89052 Phone: 702-212-5889 Fax: 702-212-5890 |
Dr. Frederick Flint Herman, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 880 Seven Hills Drive, Suite 260, Henderson, NV 89052 Phone: 702-990-4480 Fax: 702-990-4808 |
Michael J Alazard, M.D. Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 2350 W Horizon Ridge Pkwy, Henderson, NV 89052 Phone: 702-564-8556 Fax: 702-564-4485 |
News Archive
Exacerbation severity in patients with chronic obstructive pulmonary disease (COPD) can be reliably assessed with the COPD Assessment Test- (CAT), according to a new study from the UK.
Ziehm Imaging and Pie Medical Imaging BV have joined forces to make the CAAS quantification software available on mobile C-arms dedicated for cardiovascular procedures. This capability is the result of Ziehm Imaging's strategic partnership with Pie Medical Imaging BV (PMI, Maastricht, the Netherlands), a leading developer of quantitative analysis software for cardiology and radiology.
A large percentage of patients with mild-to-moderate asthma have persistently non-eosinophilic disease which may not respond to currently available anti-inflammatory treatments, according to a new study.
Women who develop high blood pressure during pregnancy are more likely to develop increased coronary calcification later in life than those who maintained a normal blood pressure, researchers said in Hypertension: Journal of the American Heart Association.
Angiochem, Inc., a clinical stage biotechnology company, today announced that its second patent has been granted by the U.S. Patent and Trademark office. Patent number 7,902,156, is entitled "Aprotinin Polypeptides for Transporting a Compound Across the Blood-Brain Barrier".
› Verified 7 days ago